January 28, 2012

The effect of combination treatment with aliskiren and blockers of the renin-angiotensin system on hyperkalaemia and acute kidney injury: systematic review and meta-analysis

.   .   

In the wake of the termination of the Altitude study, this meta-analysis identifies an increase risk of hyperkalemia but not acute kidney injury in the combination of aliskiren andĀ angiotensin converting enzyme inhibitors or angiotensin receptor blockers.

Related Articles:

Chronic Kidney Disease, Fluid & Electrolytes, RAS Blockade

Comments are closed.